[PDF][PDF] Preparation and evaluation of bilayer tablets containing metformin hydrocloride, glimepiride and pioglitazone hydrocloride

DK Gupta, M Chouhan, AK Gupta - The Pharma Innovation, 2017 - academia.edu
In proposed work, Bilayer tablets of an antidiabetes agent: Metformin, Glimepiride and
Pioglitazone hydrochloride is to formulate, and evaluate for oral sustained drug release, in …

[PDF][PDF] Current trends in pharmacological treatment of type II diabetes mellitus

PV Ingle, SB Yin, BJ Ying, BK Leong, TZ Xin… - Int J Pharmacol Res …, 2018 - researchgate.net
This review article mainly focusing on the current trends and summary of recent FDA
approved drugs for the treatment of type II diabetes mellitus. From past many years the …

A study of prescribing pattern in type-2 diabetics with co-existing hypertension

MB Rekha - 2012 - search.proquest.com
Background: Diabetes mellitus is a chronic metabolic disorder where there is defect in
insulin secretion, action or both. Hypertension and diabetes mellitus are closely interlinked …

[PDF][PDF] Design and Development of Bilayer Tablets of Metformin Hydrochloride Sustained Release and Glimepiri-de Immediate Release for the Treatment of Type 2 …

A Raj, DA Sharma - IJCMCR. 2022; 21 (2) - ijclinmedcasereports.com
The primary objective of this study was to formulate bilayer tablets of metformin
hydrochloride (sustained release) and glimepiride (immediate release) in which the dose of …

[PDF][PDF] Bacterial Profile and Antibiotic Resistance in Patients with Diabetic Foot Infections in A Tertiary Care Hospital Palakkad

S San, PA Sreeja, BL Swaroop Lal… - Inter. J. Pharma Res …, 2016 - researchgate.net
ABSTRACT BACKGROUND: Foot infections are a major complication of diabetes mellitus
and eventually lead to development of gangrene and lower extremity amputation. Many …